Key Points Core funds from operations per share fell to $0.55 and down 11.3% year-over-year (Q2 2025 vs Q2 2024). GAAP revenue declined to $188.8 million and last year's figure. Management cut ...

Wayfair's stock surged, but rising risks and stretched valuations suggest caution. See why I recommend taking profits and ...

Has the world's No. 3 cryptocurrency by market value -- up nearly 700% over the trailing-three-year period -- come too far, ...

If financial conditions are restrictive, Wall Street sure hasn’t noticed. Stock indexes hit fresh records this week, and speculative meme stocks are back to mania levels. Meanwhile, smaller businesses ...

Businesses, investors and the Fed are all operating under a cloud of uncertainty from Trump’s tariff policy. The latest moves ...

The big question on most investors' minds is whether it makes more sense to buy dips or sell rips (rallies) following the drop. Veteran analyst Tom Lee, Fundstrat's founder and head of research, ...

Stocks surged Monday, led by tech sector gains, as the market recovered from a steep decline at the end of last week that was sparked by renewed concerns about tariffs and the health of the economy.

Powered by rising margins, global growth, and confidence from management, this sleep tech stock is turning heads again. The post ResMed share price is on watch for all-time highs appeared first on The ...

IT infrastructure services provider Kyndryl (NYSE:KD) in Q2 CY2025, with sales flat year on year at $3.74 billion. Next ...

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q2 CY2025 results , with sales up 15.9% year on year to $825.4 ...

The Dow Jones index rallied, with Nvidia and Microsoft top performers. Tesla rose on the stock market today on a new pay ...